Chevron Corporation Common Stock (CVX)
sell disclosed on 15 Jan 2026 via House STOCK Act disclosures
- Transaction value
- US$15,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +9.7%
Public insider research profile
This public-disclosure research profile is not investment advice. It summarizes historical public filings, source links, confidence context, and hypothetical outcomes so readers can verify the evidence themselves.
Insider research history
Roger Williams
Public disclosure history for this insider, with previous signal outcomes and source links kept visible for research review.
20 disclosures
11 buys
9 sells
+3.2% avg. 30d outcome (20 of 20)
Insider facts
- Role
- Representative
- Country
- US
- Party
- Republican
- Type
- POLITICIAN
- Repeat disclosures
- 3
Related companies
Pfizer, Inc. Common Stock (PFE)
PFE, US, 3 disclosures
Walt Disney Company (DIS)
DIS, US, 3 disclosures
NVIDIA Corporation - Common Stock (NVDA)
NVDA, US, 2 disclosures
3K Stellantis N.V. Common Shares (STLA)
STLA, US, 1 disclosure
Alphabet Inc. - Class C Capital Stock (GOOG)
GOOG, US, 1 disclosure
Chevron Corporation Common Stock (CVX)
CVX, US, 1 disclosure
Devon Energy Corporation Common Stock (DVN)
DVN, US, 1 disclosure
Diamondback Energy, Inc. - Common Stock (FANG)
FANG, US, 1 disclosure
Eli Lilly and Company Common Stock (LLY)
LLY, US, 1 disclosure
GE Aerospace Common Stock (GE)
GE, US, 1 disclosure
Meta Platforms, Inc. - Class A Common Stock (META)
META, US, 1 disclosure
RTX Corporation Common Stock (RTX)
RTX, US, 1 disclosure
Sunshine Biopharma Inc. - Common stock (SBFM)
SBFM, US, 1 disclosure
Truist Financial Corporation Common Stock (TFC)
TFC, US, 1 disclosure
wn) JP Morgan Chase & Co. Common Stock (JPM)
JPM, US, 1 disclosure
Politician review
Historical research metrics from promoted public disclosures only. This is not investment advice.
93% avg. data confidence
- Hypothetical 30d win rate
- 12 of 20 positive outcomes
- Best reviewed outcome
- +16.1% best 30d outcome
- Weakest reviewed outcome
- -6.5% weakest 30d outcome
Repeated sectors
- Unclassified, 20 disclosures
Repeated companies
- Pfizer, Inc. Common Stock (PFE), 3 disclosures
- Walt Disney Company (DIS), 3 disclosures
- NVIDIA Corporation - Common Stock (NVDA), 2 disclosures
Disclosure history
Diamondback Energy, Inc. - Common Stock (FANG)
sell disclosed on 15 Jan 2026 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +11.8%
wn) JP Morgan Chase & Co. Common Stock (JPM)
buy disclosed on 15 Jan 2026 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -0.7%
RTX Corporation Common Stock (RTX)
buy disclosed on 15 Jan 2026 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +1.8%
Alphabet Inc. - Class C Capital Stock (GOOG)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +4.0%
Pfizer, Inc. Common Stock (PFE)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +4.6%
3K Stellantis N.V. Common Shares (STLA)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -6.5%
Sunshine Biopharma Inc. - Common stock (SBFM)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +16.1%
Truist Financial Corporation Common Stock (TFC)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +10.1%
Walt Disney Company (DIS)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.2%
Walt Disney Company (DIS)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.2%
Walt Disney Company (DIS)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -3.2%
Devon Energy Corporation Common Stock (DVN)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -0.0%
Eli Lilly and Company Common Stock (LLY)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +9.4%
GE Aerospace Common Stock (GE)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.1%
Meta Platforms, Inc. - Class A Common Stock (META)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- -1.9%
NVIDIA Corporation - Common Stock (NVDA)
buy disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +3.2%
NVIDIA Corporation - Common Stock (NVDA)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +3.2%
Pfizer, Inc. Common Stock (PFE)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +4.6%
Pfizer, Inc. Common Stock (PFE)
sell disclosed on 12 Jun 2024 via House STOCK Act disclosures
- Transaction value
- US$1,001
- Copy Window
- Probably too late
- Data Confidence
- 93%
- Previous signal outcome
- +4.6%